ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | A074359 | WATSON LABORATORIES INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Lachman Consultant Services, Inc. - Citizen Petition FDA-2008-P-0156 · 3 docket documents Lachman Consultant Services, Inc. filed this petition under Section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA declare Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules USP (50 mg/500 mg/40 mg/30 mg) suitable for submission as an ANDA, with Fiorinal | Other | 2008-09-05 | Granted | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.